Literature DB >> 16047493

Colon targeted delivery systems: review of polysaccharides for encapsulation and delivery.

Shantha L Kosaraju1.   

Abstract

Colon-targeted delivery of bioactives has recently gained importance in addressing specific needs in the therapy of colon-based diseases. Many approaches have been attempted for the development of colon-specific delivery systems, with not much success in the past. Recent research into the utilization of the metabolic activity and the colonic microenvironment in the lower gastrointestinal tract has attained great value in the design of novel colon-targeted delivery systems based on natural biodegradable polymers. In the current article, special emphasis has been placed on polysaccharide systems, with minimal chemical modification, that have been exploitedfor colon targeting. These polysaccharide based encapsulation and targeted delivery systems are envisaged to have an immense potential for the development of food/nutraceutical formulations for colon-based diseases, including colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047493     DOI: 10.1080/10408690490478091

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  18 in total

1.  Oxycellulose beads with drug exhibiting pH-dependent solubility.

Authors:  Martina Bajerová; Kateřina Krejčová; Miloslava Rabišková; Jan Muselík; Kateřina Dvořáčková; Jan Gajdziok; Ruta Masteiková
Journal:  AAPS PharmSciTech       Date:  2011-10-18       Impact factor: 3.246

Review 2.  Drug-gut microbiota interactions: implications for neuropharmacology.

Authors:  Jacinta Walsh; Brendan T Griffin; Gerard Clarke; Niall P Hyland
Journal:  Br J Pharmacol       Date:  2018-06-28       Impact factor: 8.739

3.  Characterization of soy polysaccharide and its in vitro and in vivo evaluation for application in colon drug delivery.

Authors:  B M Ursekar; P S Soni; Abhijit A Date; M S Nagarsenker
Journal:  AAPS PharmSciTech       Date:  2012-06-28       Impact factor: 3.246

Review 4.  Colon-targeted oral drug delivery systems: design trends and approaches.

Authors:  Seth Amidon; Jack E Brown; Vivek S Dave
Journal:  AAPS PharmSciTech       Date:  2015-06-13       Impact factor: 3.246

5.  Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants.

Authors:  Andi L Shane; Michael D Cabana; Stéphane Vidry; Dan Merenstein; Ruben Hummelen; Collin L Ellis; James T Heimbach; Susanne Hempel; Susan V Lynch; Mary Ellen Sanders; Daniel J Tancredi
Journal:  Gut Microbes       Date:  2010-06-16

6.  In vitro release dynamics of model drugs from psyllium and acrylic acid based hydrogels for the use in colon specific drug delivery.

Authors:  Baljit Singh; Ritu Bala; Nirmala Chauhan
Journal:  J Mater Sci Mater Med       Date:  2008-02-29       Impact factor: 3.896

7.  In Vitro and In Vivo Correlation of Colon-Targeted Compression-Coated Tablets.

Authors:  Siddhartha Maity; Amit Kundu; Sanmoy Karmakar; Biswanath Sa
Journal:  J Pharm (Cairo)       Date:  2016-02-17

8.  Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.

Authors:  Wooseong Kim; Yejin Yang; Dohoon Kim; Seongkeun Jeong; Jin-Wook Yoo; Jeong-Hyun Yoon; Yunjin Jung
Journal:  Drug Des Devel Ther       Date:  2017-02-14       Impact factor: 4.162

Review 9.  Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications.

Authors:  Anastasia Kyriakoudi; Eleni Spanidi; Ioannis Mourtzinos; Konstantinos Gardikis
Journal:  Plants (Basel)       Date:  2021-06-18

10.  The epidermal cell structure of the secondary pollen presenter in Vangueria infausta (Rubiaceae: Vanguerieae) suggests a functional association with protruding onci in pollen grains.

Authors:  Patricia M Tilney; Abraham E van Wyk; Chris F van der Merwe
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.